NCT05522387 2026-02-27An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseInmune Bio, Inc.Phase 2 Terminated11 enrolled
NCT00031551 2017-12-06Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal InjuryNational Institutes of Health Clinical Center (CC)Phase 2 Terminated27 enrolled 10 charts